Vishal Manchanda's Top Pharma Picks With Minimal US Exposure
Vishal Manchanda shares his insights on the best pharmaceutical stocks, particularly those with less exposure to the U.S. market. He highlights that Sun Pharma and Cipla have relatively minimal U.S. exposure, which makes them attractive options in the current market scenario.
